Study of Ruxolitinib in Pancreatic Cancer Patients
Public ClinicalTrials.gov record NCT01423604. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Study of Ruxolitinib Efficacy and Safety in Combination With Capecitabine for Subjects With Recurrent or Treatment Refractory Metastatic Pancreatic Cancer (The RECAP Trial)
Study identification
- NCT ID
- NCT01423604
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
- Capecitabine Drug
- Placebo Drug
- Ruxolitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2011
- Primary completion
- May 31, 2013
- Completion
- Oct 31, 2016
- Last update posted
- Feb 11, 2018
2011 – 2016
United States locations
- U.S. sites
- 39
- U.S. states
- 26
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Hot Springs | Arkansas | — | — |
| Not listed | Burbank | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Stamford | Connecticut | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Fort Myers | Florida | — | — |
| Not listed | St. Petersburg | Florida | — | — |
| Not listed | Arlington Heights | Illinois | — | — |
| Not listed | Elks Grove Village | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Sioux City | Iowa | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Novi | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Voorhees Township | New Jersey | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Lake Success | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Tulsa | Oklahoma | — | — |
| Not listed | Bend | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Danville | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Green Bay | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01423604, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2018 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01423604 live on ClinicalTrials.gov.